Investor's Business Daily on MSN32m
Janux Catapults 49% On 'Unprecedented' Results In Prostate Cancer; Vir Goes For A RideShares of Janux Therapeutics skyrocketed Tuesday on "unprecedented" results for an experimental prostate cancer treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback